Onconetix, Inc. Retained Earnings
Onconetix, Inc. (ONCO) had Retained Earnings of -$138.30 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$138.30M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$135.43M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$131.21M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$136.88M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$138.30M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$135.43M 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$131.21M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$136.88M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$128.10M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$125.40M 10-Q · filed 2025-06-12 |
| 2024-12-31 | -$115.68M 10-K · filed 2026-03-13 |
| 2024-09-30 | -$86.04M 10-Q · filed 2024-12-10 |
| 2024-06-30 | -$82.21M 10-Q · filed 2024-08-29 |
| 2024-03-31 | -$67.90M 10-Q · filed 2024-05-20 |
| 2023-12-31 | -$56.79M 10-K · filed 2025-06-02 |
| 2023-09-30 | -$34.44M 10-Q · filed 2023-11-17 |
| 2023-06-30 | -$29.09M 10-Q · filed 2023-10-20 |
| 2023-03-31 | -$22.22M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$19.38M 10-K · filed 2024-04-11 |
| 2022-09-30 | -$16.16M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$12.29M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$8.03M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$5.96M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |